Trials / Completed
CompletedNCT04926129
Natural History of the Progression of X-Linked Retinitis Pigmentosa
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 201 (actual)
- Sponsor
- NightstaRx Ltd, a Biogen Company · Academic / Other
- Sex
- All
- Age
- 7 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to gain a better understanding of disease progression over time in participants with X-linked retinitis pigmentosa (XLRP).
Detailed description
This study was previously posted by NightstaRx Ltd. In October, 2020, sponsorship of the trial was transferred to Biogen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Other: Assessments | Administered as specified in the treatment arm. |
Timeline
- Start date
- 2017-09-13
- Primary completion
- 2022-12-16
- Completion
- 2022-12-16
- First posted
- 2021-06-14
- Last updated
- 2023-02-10
Locations
22 sites across 7 countries: United States, Canada, Finland, France, Germany, Netherlands, United Kingdom
Source: ClinicalTrials.gov record NCT04926129. Inclusion in this directory is not an endorsement.